Logo image of ISPR

ISPIRE TECHNOLOGY INC (ISPR) Stock Fundamental Analysis

NASDAQ:ISPR - Nasdaq - US46501C1009 - Common Stock - Currency: USD

4.76  +0.16 (+3.48%)

After market: 4.76 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ISPR. ISPR was compared to 8 industry peers in the Tobacco industry. The financial health of ISPR is average, but there are quite some concerns on its profitability. While showing a medium growth rate, ISPR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ISPR has reported negative net income.
In the past year ISPR has reported a negative cash flow from operations.
ISPR Yearly Net Income VS EBIT VS OCF VS FCFISPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

ISPR has a Return On Assets of -14.72%. This is in the lower half of the industry: ISPR underperforms 75.00% of its industry peers.
ISPR has a Return On Equity (-61.82%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -14.72%
ROE -61.82%
ROIC N/A
ROA(3y)-6.85%
ROA(5y)N/A
ROE(3y)-25.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ISPR Yearly ROA, ROE, ROICISPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

ISPR has a worse Gross Margin (20.71%) than 62.50% of its industry peers.
In the last couple of years the Gross Margin of ISPR has grown nicely.
The Profit Margin and Operating Margin are not available for ISPR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.08%
GM growth 5YN/A
ISPR Yearly Profit, Operating, Gross MarginsISPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 5 -5 10 15

More info and screens

6

2. Health

2.1 Basic Checks

ISPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ISPR has been increased compared to 1 year ago.
ISPR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ISPR Yearly Shares OutstandingISPR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M 40M 50M
ISPR Yearly Total Debt VS Total AssetsISPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 2.29 indicates that ISPR is not a great score, but indicates only limited risk for bankruptcy at the moment.
ISPR's Altman-Z score of 2.29 is in line compared to the rest of the industry. ISPR outperforms 50.00% of its industry peers.
There is no outstanding debt for ISPR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.29
ROIC/WACCN/A
WACC9.18%
ISPR Yearly LT Debt VS Equity VS FCFISPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 10M -10M 20M -20M 30M

2.3 Liquidity

A Current Ratio of 1.13 indicates that ISPR should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.13, ISPR is doing good in the industry, outperforming 62.50% of the companies in the same industry.
A Quick Ratio of 1.05 indicates that ISPR should not have too much problems paying its short term obligations.
ISPR has a better Quick ratio (1.05) than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.05
ISPR Yearly Current Assets VS Current LiabilitesISPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

6

3. Growth

3.1 Past

ISPR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -172.56%.
The Revenue has decreased by -6.37% in the past year.
Measured over the past years, ISPR shows a very strong growth in Revenue. The Revenue has been growing by 33.80% on average per year.
EPS 1Y (TTM)-172.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-233.33%
Revenue 1Y (TTM)-6.37%
Revenue growth 3Y33.8%
Revenue growth 5YN/A
Sales Q2Q%-8.23%

3.2 Future

Based on estimates for the next years, ISPR will show a very strong growth in Earnings Per Share. The EPS will grow by 43.80% on average per year.
ISPR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.30% yearly.
EPS Next Y-3.39%
EPS Next 2Y43.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.15%
Revenue Next 2Y20.3%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ISPR Yearly Revenue VS EstimatesISPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
ISPR Yearly EPS VS EstimatesISPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 -0.1 -0.2 -0.3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ISPR. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 233.33 indicates a quite expensive valuation of ISPR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ISPR indicates a slightly more expensive valuation: ISPR is more expensive than 62.50% of the companies listed in the same industry.
ISPR's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 92.74.
Industry RankSector Rank
PE N/A
Fwd PE 233.33
ISPR Price Earnings VS Forward Price EarningsISPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150 200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ISPR Per share dataISPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

A more expensive valuation may be justified as ISPR's earnings are expected to grow with 43.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.8%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ISPR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ISPIRE TECHNOLOGY INC

NASDAQ:ISPR (2/4/2025, 8:00:02 PM)

After market: 4.76 0 (0%)

4.76

+0.16 (+3.48%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryTobacco
Earnings (Last)11-11 2024-11-11/bmo
Earnings (Next)02-25 2025-02-25/bmo
Inst Owners7.33%
Inst Owner Change0.09%
Ins Owners4.8%
Ins Owner Change41.59%
Market Cap269.65M
Analysts80
Price Target7.91 (66.18%)
Short Float %4.74%
Short Ratio13.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-14.38%
Min EPS beat(2)-63.4%
Max EPS beat(2)34.64%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-9.22%
Min Revenue beat(2)-25.34%
Max Revenue beat(2)6.9%
Revenue beat(4)1
Avg Revenue beat(4)-17.16%
Min Revenue beat(4)-35.33%
Max Revenue beat(4)6.9%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-18.42%
PT rev (3m)-18.42%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-180%
EPS NY rev (1m)-17.31%
EPS NY rev (3m)-221.05%
Revenue NQ rev (1m)-11.25%
Revenue NQ rev (3m)-19.98%
Revenue NY rev (1m)-16.69%
Revenue NY rev (3m)-36.32%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 233.33
P/S 1.82
P/FCF N/A
P/OCF N/A
P/B 8.78
P/tB 9.4
EV/EBITDA N/A
EPS(TTM)-0.34
EYN/A
EPS(NY)0.02
Fwd EY0.43%
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS2.62
BVpS0.54
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.72%
ROE -61.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.71%
FCFM N/A
ROA(3y)-6.85%
ROA(5y)N/A
ROE(3y)-25.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.08%
GM growth 5YN/A
F-Score3
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 150.69%
Cap/Sales 2.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 1.05
Altman-Z 2.29
F-Score3
WACC9.18%
ROIC/WACCN/A
Cap/Depr(3y)1179.72%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.03%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-172.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-233.33%
EPS Next Y-3.39%
EPS Next 2Y43.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.37%
Revenue growth 3Y33.8%
Revenue growth 5YN/A
Sales Q2Q%-8.23%
Revenue Next Year3.15%
Revenue Next 2Y20.3%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-287.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year18.64%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-126.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-116.45%
OCF growth 3YN/A
OCF growth 5YN/A